Strong Revenue and EPS Growth
Envista reported strong revenue and EPS growth for Q2 2025, with core growth at 5.6%. Adjusted EPS was $0.26, up $0.15 from the same quarter last year.
Margin Expansion
Adjusted EBITDA margin improved to 12.4%, up 240 basis points from Q2 2024, supported by strong growth and G&A productivity.
Broad-Based Growth Across Segments
Both reporting segments and all major geographies showed positive growth, with Equipment & Consumables up 7% and Specialty Products growing just under 5%.
Updated 2025 Guidance
Envista raised its 2025 full-year guidance, now expecting core revenue growth of 3% to 4%, up from previous expectations of 1% to 3%, and adjusted EPS of $1.05 to $1.15.
Successful Customer Engagement
The company held several high-impact customer events, such as the Nobel Biocare symposium, which was highly successful with nearly 1,700 attendees.
Improved Spark Unit Costs
Spark unit costs were reduced by more than 20% year-over-year, contributing to improved gross margins for the Spark line.